Uday Trivedi, MD

Antiplatelet and Antithrombotic Treatment After Transcatheter Aortic Valve Implantation ‚Äî Comparison of Regimes

09/26/2013

We compared procedural and follow-up complications of TAVI patients based on the type of antithrombotic treatment used (single-antiplatelet vs dual-antiplatelet vs warfarin). This relatively small series suggests that DAPT does not protect...

We compared procedural and...

09/26/2013

Journal of Invasive Cardiology

Original Contribution

Prognostic Impact of Pre-Existing Right Ventricular Dysfunction on the Outcome of Transcatheter Aortic Valve Implantation

02/27/2013

Uday Trivedi , MD;

Petra Poliacikova , MD;

Nilesh Pareek , MD;

Rachael James , MD;

Lorraine Lee ;

James Cockburn , MBBS, MD, FRCP;

Adam de Belder , MD, FRCP;

David Hildick-Smith , MD, MBBS, FRCP;

Right ventricular dysfunction is a well recognized adverse prognostic factor in patients undergoing surgical aortic valve replacement. The prognostic significance of right ventricular dysfunction in the context of transcatheter aortic valve...

Right ventricular dysfunction is...

02/27/2013

Journal of Invasive Cardiology

Original Contribution

Predicting the Need For Permanent Pacing After Implantation of the Repositionable Lotus Transcatheter Aortic Valve

09/01/2020

James Cockburn , MBBS, MD, FRCP;

Rajiv Rampat , MD;

Adam de Belder , MD, FRCP;

Roly Hilling-Smith , MD;

Maureen Dooley , MRCP, MD;

Tiffany Kemp , MD;

Andrew Hill , MD;

Uday Trivedi , MD;

Michele Homsy , MD;

David Hildick-Smith , MD, MBBS, FRCP;

Permanent pacemaker implantation rates vary according to type of transcatheter aortic valve implantation (TAVI) device, implantation technique, and patient-related factors. We analyzed the baseline characteristics, and then the preprocedure...

Permanent pacemaker implantation...

09/01/2020

Journal of Invasive Cardiology